Enjoy complimentary customisation on priority with our Enterprise License!
The heart valves market in pediatric patients size is forecast to increase by USD 1.02 billion, at a CAGR of 9.7% between 2023 and 2028. The market is witnessing significant growth due to the rising incidence of congenital heart defects (CHDs) among children. CHDs are the most common birth defects, affecting approximately 1 in every 100 infants. The increasing focus on the development of minimally invasive solutions is another major growth factor, as these procedures offer several advantages over traditional open-heart surgeries, including reduced trauma, shorter hospital stays, and faster recovery times. However, the market is also facing challenges, including the increasing shortage of skilled medical professionals, which can lead to longer wait times for patients in need of heart valve replacement or repair. Additionally, the high cost of these procedures and the lack of reimbursement policies in some regions can limit market growth.
Overall, the market is expected to grow steadily in the coming years, driven by the increasing number of pediatric patients with CHDs and the ongoing development of innovative, minimally invasive solutions.
The heart valves market in pediatric patients is witnessing significant growth due to the increasing prevalence of structural heart defects and valvular heart disease in both pediatric and geriatric populations. The advancement of technologies such as 3D printing and transcatheter valve technology is driving the market for heart valve devices. Structural heart devices, including heart valves, are increasingly being used in minimally invasive procedures, reducing patient recovery time and complications. The use of synthetic materials in heart valve devices is another major trend, providing durability and biocompatibility. The aging population and unhealthy lifestyles are contributing to the rise in heart valve surgeries.
Moreover, personalized prosthetic solutions are gaining popularity, offering better fit and functionality. Industry collaborations and healthcare investments are also boosting market growth. Medical tourism destinations offer cost-effective options for patients seeking heart valve replacement. Insurance coverage and post-surgery rehabilitation are crucial factors influencing market growth. Wearable devices for monitoring heart health and patient care are expected to further revolutionize the heart valves market in pediatric patients.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The heart valve replacement devices segment is estimated to witness significant growth during the forecast period. The market caters to the demand for essential medical devices in pediatric patients diagnosed with structural heart defects or valvular heart disease, including congenital heart disorders and conditions arising from hypertension, diabetes, or cardiovascular disease. This market comprises two major categories: mechanical heart valves and biological or tissue valves. Mechanical heart valves, fabricated from durable materials like metal, offer longevity and resistance to wear and tear. However, patients using these valves typically require ongoing medication to prevent blood clot formation. Biological valves, on the other hand, are derived from animal tissue or synthesized using 3D printing technology and transcatheter valve technology.
Similarly, these valves are more flexible and mimic the natural heart valve's function closely. Minimally invasive procedures, such as transcatheter heart valve implantation, are increasingly popular due to their reduced patient recovery time and lower surgical risks. The aging and geriatric population, unhealthy lifestyles, and rising healthcare investments fuel the growth of the Heart Valves Market. Personalized prosthetic solutions, medical tourism destinations, industry collaborations, insurance coverage, and post-surgery rehabilitation are key trends shaping the market. Wearable devices, telemedicine, and skilled healthcare professionals are also essential components of the cardiac care landscape. Despite advancements in medical technologies, surgical risks and bioengineered solutions remain critical concerns for patients and healthcare providers.
Get a glance at the market share of various segments Request Free Sample
The heart valve replacement devices segment was valued at USD 650.00 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The North American market is significantly influenced by the region's advanced healthcare infrastructure and substantial investments in medical research and technology. The US and Canada, in particular, lead the market due to their well-established medical facilities, renowned pediatric cardiology centers, and stringent regulatory frameworks. The prevalence of congenital heart diseases in the pediatric population in North America drives the demand for innovative heart valve treatments. These conditions, such as aortic stenosis and aortic regurgitation, often require minimally invasive approaches for valve replacement. Mechanical heart valves, commonly made of titanium or carbon, are popular choices for pediatric patients due to their durability and effectiveness in restoring proper heart function. The region's key companies are further expected to accelerate market growth during the forecast period.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising incidence of congenital heart defects (CHDs) among pediatrics is the key driver of the market. The Heart Valves Market encompasses a range of devices, including mechanical and biological valves, tissue valves, and transcatheter valves, used to treat structural heart defects in pediatric patients. These defects can result from conditions such as hypertension, diabetes, cardiovascular disease, and congenital heart defects. Minimally invasive procedures, enabled by advancements in technology like 3D printing and transcatheter valve technology, have become increasingly popular. Synthetic materials and biocompatible tissues are commonly used to manufacture heart valve devices. As the global population ages, the demand for cardiac care solutions, including heart valve surgeries, is expected to rise. Lifestyle choices and unhealthy lifestyles contribute significantly to the incidence of valvular heart disease and structural heart defects.
Moreover, personalized prosthetic solutions and medical tourism destinations offer cost-effective alternatives for patients seeking affordable and skilled healthcare professionals. Industry collaborations and healthcare investments in medical technologies have led to the development of wearable devices, telemedicine, and post-surgery rehabilitation programs. Insurance coverage and surgical risks are crucial factors influencing the market's growth. Bioengineered solutions, such as tissue valves and transcatheter heart valves, are gaining popularity due to their reduced surgical risks and shorter patient recovery time.
Increasingly focusing on the development of minimally invasive solutions is the upcoming trend in the market. The market is experiencing significant growth, with a focus on minimally invasive procedures using advanced technologies such as 3D printing and transcatheter heart valve technology. Structural heart devices, including heart valve devices, are increasingly being developed using synthetic materials and both mechanical and biological options. These minimally invasive approaches, such as transcatheter heart valve replacements, offer several advantages, including reduced trauma, quicker recovery, and lower surgical risks. companies are investing heavily in research and development to create personalized prosthetic solutions for pediatric patients, addressing the unique challenges of cardiovascular diseases, hypertension, diabetes, and congenital heart defects in this population. The aging and geriatric population, healthcare investments, and medical technologies continue to drive market growth.
Moreover, post-surgery rehabilitation, wearable devices, telemedicine, and skilled healthcare professionals are essential components of the cardiac care landscape. However, challenges such as surgical risks, insurance coverage, and patient recovery time remain critical considerations. Industry collaborations and medical tourism destinations offer opportunities for growth, as companies seek to expand their reach and provide innovative solutions for valvular heart disease and structural heart defects. Bioengineered solutions are also gaining traction, offering potential for long-term patient benefits.
The increasing shortage of skilled medical professionals is a key challenge affecting the market growth. The market is witnessing significant growth due to the increasing prevalence of heart valve conditions in this population. Structural heart devices, including heart valve devices, are increasingly being adopted for minimally invasive procedures, making heart valve surgeries more accessible and less risky for pediatric patients. The use of 3D printing technology and synthetic materials in the production of mechanical and biological heart valves is revolutionizing the industry. Conditions such as hypertension, diabetes, cardiovascular disease, and congenital heart defects are common in pediatric patients, leading to an increased demand for heart valve devices. Transcatheter heart valves, tissue valves, and bioengineered solutions are becoming increasingly popular due to their advantages over traditional surgical procedures, including shorter patient recovery time and reduced surgical risks.
However, the aging and geriatric population, unhealthy lifestyles, and medical tourism are driving investments in medical technologies for heart valve treatments. Industry collaborations, insurance coverage, and post-surgery rehabilitation programs are also crucial factors influencing the market's growth. Wearable devices, telemedicine, and skilled healthcare professionals are essential for effective cardiac care and valvular heart disease management. Despite these advancements, the shortage of skilled medical professionals poses a significant challenge to the market's growth, leading to delays in diagnosis and suboptimal outcomes for pediatric patients.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers pediatric heart valves such as Masters HP 15mm rotatable mechanical heart valve.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The heart valves market in pediatric patients encompasses the production and sale of heart valve devices, including mechanical and biological valves, tissue valves, and transcatheter valves. This market is driven by the increasing prevalence of cardiovascular diseases, such as hypertension, diabetes, and cardiovascular disease, in both adult and pediatric populations. Structural heart defects, including congenital heart defects, are also significant contributors to the market's growth. Advancements in medical technologies, such as 3D printing technology and transcatheter heart valve technology, are revolutionizing heart valve treatments. Minimally invasive procedures using synthetic materials and mechanical heart valves are increasingly popular due to shorter patient recovery times and reduced surgical risks.
Moreover, the aging and geriatric population, as well as the patient's age and lifestyle, are also influencing market growth. Personalized prosthetic solutions, wearable devices, telemedicine, and industry collaborations are emerging trends in the heart valves market. Insurance coverage, post-surgery rehabilitation, and skilled healthcare professionals are essential factors in the market's growth and development. Unhealthy lifestyles, such as poor diet and lack of physical activity, are contributing factors to the increasing demand for cardiac care. Valvular heart disease and structural heart defects are common conditions that require heart valve surgeries. The use of bioengineered solutions and tissue valves is also gaining popularity due to their biocompatibility and durability. Medical tourism destinations and healthcare investments are also impacting the heart valves market. The market's future growth is expected to be influenced by the increasing prevalence of cardiovascular diseases, technological advancements, and the aging population.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
169 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.7% |
|
Market growth 2024-2028 |
USD 1.02 billion |
|
Market structure |
Concentrated |
|
YoY growth 2023-2024(%) |
9.23 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key countries |
US, Canada, UK, Japan, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Artivion Inc., Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Massachusetts Institute of Technology, Medtronic Plc, Shockwave Medical Inc., TTK Healthcare Ltd., and Xeltis AG |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.